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Corneal ectatic disorders are characterized by a progressive weakening of the tissue due to biomechanical alterations of the corneal
collagen fibers. Carbon nanostructures, mainly carbon nanotubes (CNTs) and graphene, are nanomaterials that offer extraordinary
mechanical properties and are used to increase the rigidity of different materials and biomolecules such as collagen fibers. We
conducted an experimental investigation where New Zealand rabbits were treated with a composition of CNTs suspended in
balanced saline solution which was applied in the corneal tissue. Biocompatibility of the composition was assessed by means
of histopathology analysis and mechanical properties by stress-strain measurements. Histopathology samples stained with blue
Alcian showed that there were no fibrous scaring and no alterations in the mucopolysaccharides of the stroma. It also showed that
there were no signs of active inflammation.These were confirmed whenMasson trichrome staining was performed. Biomechanical
evaluation assessed bymeans of tensile test showed that there is a trend to obtain higher levels of rigidity in those corneas implanted
with CNTs, although these changes are not statistically significant (𝑝 > 0.05). Implanting CNTs is biocompatible and safe procedure
for the corneal stroma which can lead to an increase in the rigidity of the collagen fibers.
1. Introduction
Corneal debilitating disorders are characterized by progres-
sive changes of the geometry of the tissue that leads to an
irregular astigmatism that negatively impacts the patient’s
visual system [1]. There are basically two types of corneal
ectatic disorders; the first one is comprised of those patholo-
gies of primary origin, such as keratoconus and pellucidmar-
ginal degeneration, and the other kind of pathologies, that
appear secondary to a corneal photoablative procedure, is
known as Ectasia post-LASIK or Iatrogenic Keratectasia [2].
The underlyingmechanism responsible for the corneal weak-
ening that induces the aforementioned abnormalities is the
biomechanical alterations of the collagen fibers within the
corneal stroma [3–5]. Contact lens wearing, intracorneal
ring segment implantation, thermokeratoplasty procedures,
cornea transplant, and corneal collagen cross-linking have
been described as treatment alternatives to manage such a
pathological condition [6–11]. Until the date, riboflavin/UV
light exposure corneal collagen cross-linking is the only
treatment option that has proved to stop the progressive
nature of the corneal ecstatic disorders [12]. However, it is
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Figure 1: Rabbit eye at the moment of the surgical procedure showing the different steps for the creation of the pocket in the corneal stroma.
a long and uncomfortable surgical procedure for both the
patient and the surgeon and it is also a technique not exempt
of complications [12].
Carbon nanostructures, mainly carbon nanotubes
(CNTs) and graphene, have attracted great attention in the
last few years due to their small size and their extraordi-
nary physicochemical properties (they are the stiffest and
strongest materials known). Whereas graphene is a flat
monolayer of carbon atoms tightly packed into a two-dimen-
sional (2D) honeycomb lattice, carbon nanotubes can be
visualized as rolled sheets of graphene built from sp2-carbon
units. Previous studies described in the literature have
shown that carbon nanomaterials (mainly CNTs) offer
potential structural reinforcement in hydrogels to be used in
regenerative medicine due to their high mechanical strength
and good biocompatibility [13–15]. Furthermore, CNTs have
shown promising biochemical properties, such as strong
cell adhesion in multiwall carbon nanotube-coated collagen
sponge and protein absorption [16–18].
The purpose of the present investigation was to assess
if carbon nanomaterials are safe and compatible with the
ocular tissues. We also aimed to evaluate the mechanical
properties of the corneal stroma after implantation of the
CNTs. To the best of our knowledge, this is the first time
that carbon nanomaterials influence on corneal rigidity is
reported and also the first to evaluate the corneal tolerance
of such nanostructures.
2. Materials and Methods
2.1. Experimental Animals. White New Zealand rabbits were
used in this study as reference animalmodels (internationally
homologated) for the safety evaluation of new ocular con-
cepts. Animal care and treatment procedures were in accor-
dance with the standards of the EU Directive 2010/63/EU for
animal experiments, in conformity to National Guidelines
for animal usage in research and with the regular rules (Real
Decreto 53/2013) of the Animal Experimentation Service of
the Miguel Hernandez University, Alicante, Spain and after
the Ethics Experimental Animal Committee approval.
Twenty-four eyes of white New Zealand rabbits were
included in this study. The animals were anesthetized with
subcutaneous injections of a mixture of ketamine hydrochlo-
ride 20mg/kg (Imalgene 1000; Merial, Lyon, France) and
xylazine hydrochloride 4mg/kg (Xilagesic 2%; Laboratorios
Calier, Barcelona, Spain), and ocular topic double anesthetic
(tetracaine 0.1% and oxibuprocaine 0.4%, Colircusi; Alcon
Cusi SA, Barcelona, Spain). The study was designed based
on four experimental animal groups as follows: Group 1
(Control group): 5 eyes in which no surgical procedure
was performed; Group 2 (Pocket group): 5 eyes in which
a space (pocket) was created in the middle of the corneal
stroma. In order to create the pocket, we first marked a
6mm diameter circle on the surface of the cornea. Then
a vertical incision of 300 microns in depth was performed
using a calibrated diamond knife. Finally, the dissection of the
corneal stroma through an area of 6mm and at 300 microns
in depth was performed using a minicrescent surgical knife
(Figure 1). Group 3 (Reference 1 group) was 7 eyes in which
a pocket was created and a dispersion composed of carbon
nanotubes (CNTs) mixed with saline solution was injected
inside the pocket. The concentration of this composition was
0.1mg/mL. Group 4 (Reference 2 group) was 7 eyes in which
a pocket was created and a dispersion composed of CNTs
mixedwith saline solutionwas injected inside the pocket.The
concentration of this composition was 1mg/mL (Figure 2).
Antibiotic prophylaxis was topically applied using Tobra-
mycin/Dexamethasone (Tobradex, Alcon) and Chloram-
phenicol ointment (Oftalmolosa Cusi, Alcon) twice a day
for 7 days. Subcutaneous Buprenorphine (0.05mg/kg) and
Paracetamol in drinking water (100mg/mL) were also used
as analgesic for the first days after surgery.
After the injection of the composition containing CNTs,
the rabbits were kept under observation for a period of 3
months.
Afterwards, euthanasia was performed in rabbits and a
corneoscleral rim of approximately 15mm in diameter was
dissected for histopathology and biomechanical evaluations.
2.2. Preparation of Carbon Nanotubes. Single wall carbon
nanotubes (SWCNTs) were used in the current experimental
protocol. SWCNTswere prepared by laser ablation of a graph-
ite rod in the presence of Cobalt (Co) andNickel (Ni) accord-
ing to previous recipes reported in the literature [19, 20].
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Figure 2: Appearance of the dispersion composed of carbon nan-
otubes (CNTs) mixed with saline solution in which concentration is
1mg/mL.
Synthesized SWCNTs were purified using 15% hydrogen
peroxide solution under reflux at 100∘C for 5 hours to remove
the amorphous carbons. The residual catalysts of Ni and Co
were removed by 1M hydrogen chloride solution, followed
by a washing step using double distilled water. Synthesized
SWCNTs were dissolved in physiological solution (buffer
saline solution) before being incorporated in the cornea
using a final concentration of 0.1mg/mL and 1mg/mL (see
Figure 2).
2.3. Histopathology Evaluation. After euthanasia, a piece of
the corneal bottomswas dissected and fixed in 10%phosphate
buffered formaldehyde until tissue processing. The safety
and biocompatibility of the CNTs dispersion composition in
the corneal tissue were assessed by means of histopathology
examination of the samples 3 months after the surgery.
Histological sections were obtained with a thickness of 3
microns and were stained with Hematoxylin and Eosin, blue
Alcian, and Masson’s trichrome.
2.4. Biomechanical Evaluation. Mechanical properties of the
cornea were analyzed by performing stress-strain measure-
ments in order to determine the modulus of elasticity of
the corneal tissue. For this purpose, we dissected a strip of
corneoscleral tissue with a dimension of 5 × 15mm that then
was clamped into a Microtest SCM 3000 95 universal testing
machine in tensile mode (Microtest SA, Madrid, Spain) with
load cell of 15N at room temperature. By means of strain
control, samples underwent deformation in a ramp with a
constant speed of 1mm/min. The equipment registered the
force that was necessary to perform this deformation, and
then with the data that was obtained, stress/strain graphics
were drawn. Young’s modulus of the samples was obtained
as the slope of the linear region in the stress-strain curve
at approximately 10% strain. Yield strength was calculated
as the stress at which this linear behaviour is finished;
that is, it began to deform plastically. Failure strain was
calculated at the point at which the sample started to break.
Between five and seven measurements were performed for
each group. Results are given as the average plus/minus
standard deviation.
2.5. Statistical Analysis. The statistical analysis was carried
out using the one-way analysis of variance (ANOVA) with R
3.1.0 software.The level of statistical significancewas𝑝 < 0.05
in all cases.
3. Results
3.1. Clinical Evaluation. The present investigation was per-
formed by means of an experimental protocol where 24 eyes
of New Zealand white rabbits were implanted with CNTs
in the corneal stroma and were kept under observation
during a period of 3 months. Figure 3 corresponds to a series
of images showing the rabbit’s eyes at the moment of the
surgical procedure, 7 days after CNTs implantation, and at
3 months during the last follow-up. At the moment of the
surgery, the CNTs can be appreciated, using the surgical
microscope under high magnification, as small black dots
distributed along the previously performed corneal pocket.
Oneweek after the procedure, the corneal tissue is completely
transparent, with no epithelial defect, without corneal edema
and no signs of stromal or anterior chamber inflammation.
At three months, the corneal tissue remains transparent, with
the small black dots corresponding to the CNTs implanted
and no clinical signs of ocular inflammation. There were no
complications in any of the 14 eyes implanted with the CNTs
and there was no need of an early euthanasia in any of the
rabbits during the follow-up period.
3.2. Histopathology Evaluation. Figure 4 shows a sample of
corneal stroma, where the collagen fibers are oriented verti-
cally and stained with blue Alcian to illustrate that there are
no fibrous scaring and no alterations in the mucopolysaccha-
rides of the corneal stroma. It also shows that there are no
signs of active inflammation after the procedure. The latest is
confirmed when theMasson trichrome staining is performed
(Figure 5: solid red arrows showing the carbon nanotubes
within the corneal tissue). Figure 6 illustrates another sample,
again vertically oriented, stained with Masson trichrome to
show that there is no inflammation and no foreign body giant
cell reaction against the CNTs implanted. It also shows a
stronger adhesion of the tissue in the area surrounding the
CNTs. Other interesting findings that were observed in the
pathology report were the absence of neovascularization and
that there was no apoptosis of the keratocytes on the samples
examined.
3.3. Biomechanical Evaluation. Figure 7 shows a typical
stress-strain curve, where several regions can be observed.
Onone hand, the so-called toe region can be observed, typical
in most soft tissues, where the relation between stress and
strain is not linear, and the slope increases with stress. On
the other hand, the elastic region can be observed, where the
relation between the stress and the strain is almost linear.
In this region, Young’s modulus is calculated as the slope
of the straight line (red line in Figure 7). When the stress
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Figure 3: Same eye of a rabbit at the moment of the surgical procedure (A), 7 days after CNTs implantation (B) and at 3 months after the
surgery (C).
Figure 4:Corneal stroma sample in vertical orientation stainedwith
blue Alcian.
Figure 5: Corneal stroma sample in horizontal orientation stained
with Masson trichrome. Solid red arrows showing the CNTs within
the corneal tissue.
Figure 6: Corneal stroma sample vertically oriented with Masson
trichrome staining. Red circle showing the strong adhesion of the
tissue around the CNTs.
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Figure 7: Typical stress-strain curve. Blue points represent the
experimental data, and red straight line, the linear fitting used to
obtain Young’s modulus.
is increased above the elastic region, the shape of the curve
changes and the plastic regions begin. In this region the tissue
suffers nonreversible changes.The tissue is not able to recover
its original shape in case the force is removed. Finally, the
breakdown point of the tissue is reached [21].
Table 1 shows Young’s modulus, yield stress, and failure
strain obtained for each one of the samples. It can be seen
fromYoung’smodulus that there was a trend towards a higher
rigidity for the Reference 2 sample (CNTs 1mg/mL), although
this difference was not statistically significant (𝑝 > 0.05). The
yield stress increased for References 1 and 2 compared to the
Control sample.However, this differencewas only statistically
significant for Reference 1 (𝑝 < 0.05). Also, for Reference 2
there was an increase of the failure strain, but again it was not
statistically significant (𝑝 > 0.05).
4. Discussion
Thepresent study evaluates the safety and biocompatibility of
carbonnanotubes (CNTs) in ocular tissues. It also assesses the
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Table 1: Number of sample data sets (𝑛), Young’s modulus, yield stress, and failure strain obtained in each one of the samples.
Group 𝑛 Young’s modulus (MPa) Yield stress (MPa) Failure strain
Control 5 12.1 ± 2.5 1.4 ± 0.3 0.40 ± 0.06
Pocket 6 12.0 ± 4.2 1.9 ± 1.0 0.39 ± 0.08
Reference 1 5 11.8 ± 1.3 2.3 ± 0.3 0.47 ± 0.05
Reference 2 7 13.0 ± 3.9 1.9 ± 0.6 0.41 ± 0.07
capability of the nanomaterials to increase the biomechanical
properties in the corneal stroma. To the best of our knowl-
edge, this is the first scientific investigation that evaluates the
behaviour of carbon nanomaterials in ocular tissues.
The unique characteristics of CNTs have kept the atten-
tion in many areas within the scientific arena, such as
electronics, physics, and mechanics. Also, in nanomedicine
the interest for these materials has significantly grown during
the last decade as advances in technology allow isolating
and developing pure forms of carbon nanostructures. As
nanotechnology is defined by the size of a material (generally
1–100 nm) or manipulation on the molecular level, it involves
a broad range of nanoscaledmaterials used in various fields of
biology andmedicine [22]. Nanotechnology offers promising
perspectives in biomedical research as well as in clinical
practice. The high versatility of carbon nanomaterials brings
many opportunities as therapeutic agents in the field of
nanomedicine. Among the different interesting and unique
properties that characterized carbon nanostructures, its bio-
compatibility, optical transparency, and mechanical proper-
ties make these structures an excellent option to develop
new alternatives of personalized medicine and treat several
pathologies in the ophthalmology field.
Corneal ectatic disorders are characterized by a progres-
sive corneal thinning that induces alterations in the mor-
phology of the cornea, which negatively impacts the patient’s
visual function. The mechanical stability of the cornea is pri-
marily determined by the structure of the collagen molecules
and their spatial arrangement, which is orthogonal in normal
patients. However, the equilibrium of this architecture is
lost in eyes with ectatic corneal pathologies, which leads
to biomechanical alterations that are responsible for the
instability and weakness of the tissue in these diseases [3]. To
this day, the only surgical technique that has demonstrated
to stabilize and stop the progressive nature of these disorders
is riboflavin UV-A light corneal collagen cross-linking (CXL)
[12]. This procedure increases the stiffness of the cornea by a
photo oxidative reaction that creates covalent bonds between
the collagen fibers of the corneal tissue [12]. However, it is a
very long surgical procedure, which makes it uncomfortable
for both the surgeon and the patient. Additionally, because of
the phototoxic effect of the UV light, it cannot be performed
in thin corneas, which is characteristic in ectatic disorders
and may present some complications related to the epithelial
debridement as well as alterations in the transparency of
the tissue. Therefore, using carbon nanomaterials in order
to reinforce the corneal stroma will have several advantages
as an alternative therapeutic option for such pathological
conditions due to the excellent mechanical properties that
characterized these nanostructures and also because most of
the limitations related to the current treatment options can be
avoided.
In the present investigation, biocompatibility of CNTs
in ocular tissues was assessed by means of histopathology
evaluation. It was found that carbon nanomaterials do not
induce any inflammatory or foreign body reaction in the
corneal stroma. Biocompatibility of CNTs has been pre-
viously reported in other fields of biology and medicine,
for example, tissue engineering, regenerative medicine, drug
delivery systems, and reinforcement of biological tissues
[22–24]. Zhao et al. specifically evaluated the cytocompat-
ibility and hemocompatibility of CNTs by cell adhesion
assays and hemolytic rate experiments [23]. They concluded
that CNTs did not interfere with the viability, metabolic
activity, morphology, and spreading of either of the cell
types analyzed. In the same way, Koyama and colleagues
observed low toxicity and stable (almost inert) biological
response by analyzing the systematic study of T-cells in
peripheral blood in in vivo experimental animals [24]. In
another study, Tan et al. evaluated the biocompatibility of
CNTs composites by seeding these nanomaterials together
with pulmonary arterial endothelial cells. Results from this
study demonstrated high levels of cell viability and adhesion,
thus showing excellent biocompatibility of the CNTs [17]. In
addition, there are several authors that have analyzed the
biological response of these materials in different types of
cells and they have found that CNTs are biologically inert and
do not show toxicity on the tissues that were evaluated and
also that these nanomaterials are cleared by circulation when
injected intravenously [25–29].
In the current study, the mechanical properties of the
cornea after being implanted with CNTs were also evaluated.
The module of elasticity was assessed by means of stress-
strain measurements in order to determine which of the
samples under analysis showed the most rigid behaviour.
Even though a trend towards stiffer results in those samples
treated with the higher concentration of CNTs was found, the
differences were not statistically significant when compared
with those samples untreated. Therefore, if we want to
introduce a reinforced material to another material, it is clear
that an interactionmust exist between thematerials involved.
In the present study, interactions between the CNTs
and the collagen fibers of the corneal stroma were not
assessed. Nevertheless, there are some investigations that
have demonstrated the adsorption and interaction that is
present when combining carbon nanomaterials and collagen
fibers by means of theoretical models. Using molecular
dynamics simulation, Cazorla characterized the quantum
interaction that exists between carbon based nanostructures
and collagen-like peptides [30]. In addition, other authors
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Figure 8: Schematic representation of a cross section of the cornea. (A) Cornea without carbon nanostructures. (B) Cornea with carbon
nanostructures in the area where the pocket was created as it was performed in the current study. (B1) Histopathology sample stained with
Masson trichrome corresponding to one of the corneas analyzed in the present work where carbon nanostructures can be found just in the
area where the stromal pocket was created (red circle). (C) Schematic representation of the cross section of the cornea with an increased
distribution of carbon nanomaterials.
have reported the interaction and adsorption that is present
between collagen fibers and carbon nanomaterials by using
finite elements analysis and density functional theory [31]. In
the sameway, aggregation between the collagen fibers and the
CNTs has also been demonstrated bymeasuring the turbidity
of the suspension [32]. There are other investigations in
which qualitative and chemical assessment have been carried
out in order to evaluate the interaction between collagen
fibers and carbon nanostructures. Akasaka and col. evaluated
the interaction between CNTs and collagen using scanning
electron microscopy (SEM) [33]. The authors concluded that
CNTs interact strongly and blend with collagen fibers. In
the same way, Tosun and McFetridge performed qualitative
analysis using SEM and also found an increase in adsorption
between the single wall carbon nanotubes and collagen
hydrogels [34]. Moreover, this interaction between CNTs
and collagen fiber has also been studied using a chemical
approach. In the aforementioned study performed byTan and
colleagues, the relationship betweenCNTs and collagen fibers
was also analyzed by spectrometry analysis [17]. Additionally,
Cao et al. also evaluated the chemical interaction bymeans of
Fourier transform infrared spectroscopy and they specifically
observed that the carboxylic and hydroxyl groups present on
the surface of CNTs form covalent and hydrogen bonds with
the amino groups of the collagen fibers [16]. As we can see,
there is enough scientific evidence published in the literature
that has demonstrated the interaction that exists between the
CNTs and the collagen by means of theoretical, qualitative,
and quantitative assessment. Finally, some of these reports
observed that this interaction leads to an increase of the
mechanical properties in the collagen. Cao et al. specifically
found an increase of the static tensile modulus and strength
of the collagen with the addition of CNTs [16]. Tosun and
McFetridge also reported that the collagen gels treated with
CNTs displayed a significant increase in material stiffness
when evaluated by unconfined compression analysis [34].
Nevertheless, as previously mentioned, in the current inves-
tigation, even when we observed a trend towards increasing
the mechanical properties of the samples treated with CNTs,
these changes were not statistically significant. There are
some variables, like the small sample under analysis and
the methodology used in order to evaluate the mechanical
properties, which could have been related to this behaviour.
However, we consider that the most important factor that
could explain the limited enhancement of the mechanical
properties of the samples in our study is that CNTs were
inducing their effect on just a small area of the cornea,
specifically where the pocket was created (Figure 8). Hence,
it is our hypothesis that it is necessary to obtain a more
homogeneous distribution of the carbon nanomaterials all
over the stroma in order to achieve a significant increase of
the mechanical properties in the cornea (Figure 8).
Optimized alternatives including other types of carbon
nanomaterials, such as graphene, incorporating drug delivery
systems to enhance the penetration and distribution of
carbon nanomaterials along the corneal stroma and increas-
ing their chemical properties via functionalization are now
being developed by our research group. This will certainly
improve the biocompatibility, the optical transparency, and
the capacity of these materials to conjugate and interact with
other biomolecules, such as corneal collagen fibers.
5. Conclusions
In conclusion, histopathology evaluation shows the biotol-
erance and biocompatibility of carbon nanostructures after
being implanted in the corneal stroma. The corneal biome-
chanical evaluation, as performed in this investigation, shows
that there is a trend to obtain more rigidity of the corneal
tissue after carbon nanostructures implantation, although
these changes were not statistically significant. To the best
of our knowledge, this is the first study that aims to assess
the biocompatibility and biomechanical properties of the
cornea after being implanted with carbon nanomaterials.
Thus, further research is necessary in order to comprehend
and improve the biomechanical assessment of the present
investigation and also to understand the potentials use of
these materials and this novel technology for the develop-
ment of new applications of nanomedicine in visual sciences.
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